How Biologics Work to Treat and Manage MS Symptoms
Multiple Sclerosis (MS) poses a significant healthcare challenge.
A study by the National MS Society indicates that nearly one million people live with MS in the United States, more than twice the previous estimates.
This emphasizes the urgency of finding effective solutions to address the needs of this growing population.
Watch the video: Exercise and IBD: How Biologics Work to Treat and Manage MS Symptoms
The Key Role of Biologics in MS Treatment
Biologics have emerged as transformative agents in MS therapy, offering targeted approaches to modulate the immune system and mitigate disease activity.
Unlike conventional disease-modifying therapies, biologics specifically target critical components of the immune response, thereby reducing inflammation and thwarting further damage to the central nervous system.
Mechanisms of Action
In recent years, the FDA has approved several biologic drugs for treating Multiple Sclerosis. While these approved medications offer benefits, they each work differently.
Ocrevus® (ocrelizumab), a monoclonal antibody, targets CD20-positive B cells, leading to their depletion from the peripheral blood.
By reducing the number of circulating B cells, Ocrevus® helps dampen the inflammatory response and mitigate damage to myelin in patients with relapsing or primary progressive MS.
Tysabri® (natalizumab) operates by blocking the interaction between α4-integrin on leukocytes and vascular cell adhesion molecule-1 (VCAM-1) on endothelial cells, thereby preventing the migration of autoreactive immune cells from the bloodstream into target organs and damaging the central nervous system.
This mechanism helps reduce inflammation and the formation of new lesions in patients with relapsing forms of MS.
Lemtrada® (alemtuzumab) targets CD52, a protein found on the exterior of T and B lymphocytes, leading to their depletion.
By resetting the immune system, Lemtrada® helps control disease activity and delay the progression of disability in patients with relapsing forms of MS.
Altus Biologics – Empowering Neurologists to Deliver In-Office Biologic Therapies
As the prevalence of MS continues to rise, you’ve probably experienced the challenge of meeting the increasing demand for specialized care.
Altus Biologics offers comprehensive support services to streamline the integration of biologic therapies into existing clinical practice.
Altus Biologics equips you with the tools and expertise needed to deliver personalized care to your MS patients, including:
Comprehensive Support Services
Altus Biologics provides comprehensive support services to optimize every aspect of the biologic therapy process.
We handle most aspects of your in-office infusion suite, including site setup, patient benefits verification, drug administration, and monitoring.
Efficient Drug Procurement and Revenue Cycle Management
Altus Biologics streamlines the drug procurement and distribution process, ensuring you have timely access to biologic therapies for your patients.
By partnering with Altus Biologics, you can avoid the complexities associated with drug procurement, inventory management, and reimbursement, allowing you to focus on delivering high-quality care to your patients without interruption.
Drug Administration and Clinical Support
Altus Biologics’ infusion nurses work hand-in-hand with you and your staff to optimize treatment outcomes and enhance patient satisfaction.
Altus Biologics is a trusted partner for neurologists nationwide seeking to integrate biologic therapies into their practice.
Our comprehensive support services and expertise empower you to deliver in-office biologic therapies with confidence, efficiency, and compassion.
Contact us today to learn more about our services. Together, we can transform the landscape of MS management and improve outcomes for every patient living with this complex neurological condition.
